Description:

AMC-045 Chemistries, LFT's (F23) Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer https://clinicaltrials.gov/ct2/show/NCT00324415

Link:

https://clinicaltrials.gov/ct2/show/NCT00324415

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 6/9/17
Uploaded on:

June 9, 2017

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

HIV Anal Cancer Therapy NCT00324415 AMC-045

Details

No Instruction available.

  1. StudyEvent: AMC-045 Chemistries, LFT's (F23)
    1. No Instruction available.
Header Module
mm/dd/yyyy
Reporting Period (select one)
Ccrr Module For Chemistries, Lft's - Rf23
mmol/L
mmol/L
mEq/L
mmol/L
mEq/L
mU/ml
mU/ml
mg/dl
mg/dL
mg/dl
mg/dl
g/dl
Back to the top of the page